Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study

Sophia Dobischok,1 Rebecca K Metcalfe,1 Elizabeth Angela Matzinger,1 Kurt Lock,1,2 Scott Harrison,3 Scott MacDonald,3 Sherif Amara,4 Martin T Schechter,1,5 Nick Bansback,1,5 Eugenia Oviedo-Joekes1,5 1Centre for Health Evaluation & Outcome Sciences, Providence Health Care, Vancouver, BC, Canada;...

Full description

Bibliographic Details

Published in:	Patient Preference and Adherence
Main Authors:	Dobischok S, Metcalfe RK, Matzinger EA, Lock K, Harrison S, MacDonald S, Amara S, Schechter MT, Bansback N, Oviedo-Joekes E
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-12-01
Subjects:	opioid use disorder opioid agonist treatment injectable opioid agonist treatment diacetylmorphine hydromorphone best worst scaling
Online Access:	https://www.dovepress.com/feasibility-of-testing-client-preferences-for-accessing-injectable-opi-peer-reviewed-fulltext-article-PPA